0001157523-23-001058.txt : 20230630 0001157523-23-001058.hdr.sgml : 20230630 20230630081710 ACCESSION NUMBER: 0001157523-23-001058 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230630 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230630 DATE AS OF CHANGE: 20230630 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MOLINA HEALTHCARE, INC. CENTRAL INDEX KEY: 0001179929 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 134204626 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31719 FILM NUMBER: 231059518 BUSINESS ADDRESS: STREET 1: 200 OCEANGATE, SUITE 100 CITY: LONG BEACH STATE: CA ZIP: 90802 BUSINESS PHONE: 5624353666 MAIL ADDRESS: STREET 1: 200 OCEANGATE, SUITE 100 CITY: LONG BEACH STATE: CA ZIP: 90802 FORMER COMPANY: FORMER CONFORMED NAME: MOLINA HEALTHCARE INC DATE OF NAME CHANGE: 20020812 8-K 1 a53438085.htm MOLINA HEALTHCARE, INC. 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________
FORM 8-K
______________

Current Report

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 30, 2023 (June 30, 2023)
 
______________
 
MOLINA HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)

Delaware
001-31719
13-4204626
(State or other jurisdiction of
incorporation)
(Commission File Number)
(IRS Employer Identification No.)
 
______________
 
200 Oceangate, Suite 100, Long Beach, California 90802
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (562) 435-3666
 
 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.001 Par Value
MOH
New York Stock Exchange
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
   
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act.
☐

Item 7.01.    Regulation FD Disclosure.
 
On June 30, 2023, Molina Healthcare, Inc. (the “Company”) announced that it has entered into a definitive agreement to acquire Brand New Day and Central Health Plan of California, each of which is a wholly owned subsidiary of Bright Health Company of California, Inc. The full text of the Company’s press release issued in connection with the announcement is included as Exhibit 99.1 to this report.
 
Note: The information in this Form 8-K and Exhibit 99.1 attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
 
Item 9.01.    Financial Statements and Exhibits.

(d)       Exhibits:
 
Exhibit No.
Description
   
104
Cover Page information from Molina Healthcare, Inc.’s Current Report on Form 8-K filed on June 30, 2023 formatted in iXBRL (Inline Extensible Business Reporting Language)

SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 
 MOLINA HEALTHCARE, INC.
 
 
 
 
 
 
Date:     June 30, 2023 By:
 /s/ Jeff D. Barlow
 
 
 Jeff D. Barlow
 
 
 Chief Legal Officer and Secretary
 
 EX-99.1 2 a53438085_ex991.htm EXHIBIT 99.1
Exhibit 99.1

Molina Healthcare to Acquire Bright HealthCare’s California Medicare Business

Transaction expands Molina’s Medicare presence in California and is expected to add $1.00 per share to new store embedded earnings1

LONG BEACH, Calif.--(BUSINESS WIRE)--June 30, 2023--Molina Healthcare, Inc. (NYSE: MOH) (“Molina” or the “Company”) announced today that it has entered into a definitive agreement to acquire 100% of the issued and outstanding capital stock of Brand New Day and Central Health Plan of California (collectively, the “CA Health Plans”), each of which is a wholly owned subsidiary of Bright Health Company of California, Inc (“BHCA”). Relevant transaction terms and features are as follows:

  • The purchase price for the transaction is approximately $510 million, net of certain tax benefits, representing 28% of expected 2023 premium revenue of $1.8 billion.
  • BHCA currently offers MAPD, D-SNP, and C-SNP products in 23 counties in California, with 60% overlap with Molina’s Medicaid footprint. As of March 31, 2023, BHCA served approximately 125,000 members.
  • The transaction represents a strong strategic fit with Molina’s expanded 2024 Medi-Cal contract. It accelerates Molina’s D-SNP growth initiatives and activates the Los Angeles County 2024 D-SNP option the Company had negotiated with the state.
  • Today’s announcement is expected to add $1.00 per share to new store embedded earnings, bringing the expected total to $5.50 per share2.

“These additions fit perfectly with our strategy of serving high-acuity, low-income members and represent a textbook execution of our growth playbook. We acquire viable assets at attractive valuations, then deploy our proven team of operators to deliver improved financial results,” said Joe Zubretsky, President and Chief Executive Officer of Molina. “We are pleased to continue our meaningful growth in California as the latest realization of our national growth strategy.”

Molina intends to fund the purchase with available funds including cash on hand. The transaction is subject to federal and state regulatory approvals, the solvency and continued operation as a going concern of Bright Health Group throughout the pre-closing period, and other closing conditions. It is expected to close in the first quarter of 2024.

About Molina Healthcare

Molina Healthcare, Inc., a FORTUNE 500 company (currently ranked 126), provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. Molina Healthcare served approximately 5.3 million members as of March 31, 2023, located across 19 states. For more information about Molina Healthcare, please visit molinahealthcare.com.

1 See Reconciliation note below
2 Idem

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995. This press release contains forward-looking statements regarding our intended acquisition of Brand New Day and Central Health Plan of California, including the anticipated timing of the closing of the acquisition and our expected new store embedded earnings. All forward-looking statements are based on current expectations that are subject to numerous risk factors that could cause actual results to differ materially. Such risk factors include, without limitation, risks that the transaction may not close on a timely basis or at all, our ability to obtain regulatory approvals and third-party consents and to satisfy all closing conditions, our ability to integrate the acquisition as currently expected without unreasonable delay or cost, and our ultimate realization, as expected, of embedded earnings and our non-recurring costs associated with the recently announced acquisitions. Additional risk factors to which the Company is subject are provided in our periodic reports and filings with the Securities and Exchange Commission, including the Company’s most recent Annual Report on Form 10-K. These reports can be accessed under the investor relations tab of the Company’s website or on the SEC’s website at sec.gov. Given these risks and uncertainties, the Company cannot give assurances that its forward-looking statements will prove to be accurate. All forward-looking statements represent the Company’s judgment as of the date hereof.

Non-GAAP Financial Measures

The Company includes in this release the financial measure, “new store embedded earnings,” which is a non-GAAP measure. The term is defined as the incremental diluted earnings per share impact that we expect to achieve in future years related to newly awarded but not yet commenced state Medicaid contracts, and recently closed and announced acquisitions. The incremental impact reflects the expected full-year earnings for the newly-awarded California, Iowa, Nebraska, and Indiana Medicaid contracts, and the Agewell, MyChoice Wisconsin, and California Medicare Health Plans acquisitions, not yet included in the current full-year guidance issued by the Company. This measure excludes amortization of intangible assets and non-recurring costs associated with acquisitions, including various transaction and integration costs. The Company and management believe this measure is useful to investors in assessing the Company’s expected performance related to new Medicaid contracts and acquisitions, and is used internally to enable management to assess the Company’s performance consistently over time. New store embedded earnings should be considered as a supplement to, and not as a substitute for or superior to, GAAP measures. Management is unable to reconcile this measure to the growth in GAAP earnings per share, the most directly comparable GAAP measure, without unreasonable effort due to the unknown impact from the amortization of intangible assets related to recently announced acquisitions, which cannot be determined until purchase accounting valuations are completed. Non-recurring costs associated with the recently announced acquisitions are estimated at approximately $15 million.

Contacts

Investor Contact: Joseph Krocheski, Joseph.Krocheski@molinahealthcare.com, 562-549-4100
Media Contact: Caroline Zubieta, Caroline.Zubieta@molinahealthcare.com, 562-951-1588

EX-101.SCH 3 moh-20230630.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 moh-20230630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name EX-101.PRE 5 moh-20230630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Document and Entity Information
Jun. 30, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jun. 30, 2023
Entity Registrant Name MOLINA HEALTHCARE, INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-31719
Entity Tax Identification Number 13-4204626
Entity Address, Address Line One 200 Oceangate, Suite 100
Entity Address, City or Town Long Beach
Entity Address, State or Province CA
Entity Address, Postal Zip Code 90802
City Area Code 562
Local Phone Number 435-3666
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0001179929
Title of 12(b) Security Common Stock, $0.001 Par Value
Trading Symbol MOH
Security Exchange Name NYSE
XML 7 a53438085_htm.xml IDEA: XBRL DOCUMENT 0001179929 2023-06-30 2023-06-30 false 0001179929 8-K 2023-06-30 2023-06-30 MOLINA HEALTHCARE, INC. DE 001-31719 13-4204626 200 Oceangate, Suite 100 Long Beach CA 90802 562 435-3666 false false false false Common Stock, $0.001 Par Value MOH NYSE false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 1 22 1 false 0 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://molinahealthcare.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports a53438085.htm a53438085_ex991.htm moh-20230630.xsd moh-20230630_lab.xml moh-20230630_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "a53438085.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "contextCount": 1, "dts": { "inline": { "local": [ "a53438085.htm" ] }, "labelLink": { "local": [ "moh-20230630_lab.xml" ] }, "presentationLink": { "local": [ "moh-20230630_pre.xml" ] }, "schema": { "local": [ "moh-20230630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] } }, "elementCount": 29, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "moh", "nsuri": "http://molinahealthcare.com/20230630", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "a53438085.htm", "contextRef": "c20230630to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://molinahealthcare.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "a53438085.htm", "contextRef": "c20230630to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "trueItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://molinahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0001157523-23-001058-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001157523-23-001058-xbrl.zip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end